# Safety and Efficacy Study of Vaginal Misoprostol for Cervical Ripening and Induction of Labor

> **NCT01428037** · PHASE3 · COMPLETED · sponsor: **Regenex Pharmaceutical, China** · enrollment: 225 (actual)

## Conditions studied

- Cervical Ripening
- Induction of Labor

## Interventions

- **DRUG:** Placebo
- **DRUG:** Misoprostol vaginal Tablet 25 mcg

## Key facts

- **NCT ID:** NCT01428037
- **Lead sponsor:** Regenex Pharmaceutical, China
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 225 (ACTUAL)
- **Last updated:** 2013-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01428037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01428037, "Safety and Efficacy Study of Vaginal Misoprostol for Cervical Ripening and Induction of Labor". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01428037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*